Rapid heparin anticoagulaion: Use of a weight-based nomogram

American Family Physician

Volumn 54, Issue 8, 1996, Pages 2517-2521

  Schaefer, David C ^a   Hufnagle, Jan ^b   Williams, Lewis ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YORK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BODY WEIGHT; DEEP VEIN THROMBOSIS; HEPARINIZATION; HUMAN; LUNG EMBOLISM; NOMOGRAM; OBESITY; BLOOD; BODY HEIGHT; DRUG ADMINISTRATION; REVIEW;

ANTICOAGULANTS; BODY HEIGHT; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; HEPARIN; HUMANS; OBESITY;

EID: 0029658194     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-14.
2. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
3. Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch Intern Med 1988;148:1321-5.
4. Fennerty AG, Thomas P, Backhouse G, Bentley P, Campbell IA, Routledge PA. Audit of control of heparin treatment. Br Med J 1985;290:27-8.
5. Kershaw B, White RH, Mungall D, Van Houten J, Brettfeld S. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Arch Intern Med 1994;154:1005-11.
6. Ellison MJ, Sawyer WT, Mills TC. Calculation of heparin dosage in a morbidly obese woman. Clin Pharm 1989;8:65-8.
7. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med 1993;119:874-81.
8. Groce JB 3d, Gal P, Douglas JB, Steuterman MC. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time. Clin Pharm 1987;6:216-22.
9. Allen TH, Peng MT, Chen KP, et al. Prediction of blood volume and adiposity in man from body weight and cube height. Metabolism 1956;5:328-45.
10. Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 1985; 42:1965-9.
11. Schaefer DC, Hufnagel J, Williams L. Anticoagulation inadequacy: the weight factor. Juried paper presented at the 1994 Annual Session of the American College of Physicians, April 21-24, 1994, Miami, Fla.
12. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7.
13. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GF, Baylis B, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95.
14. Levine M, Hirsh J. Hemorrhagic complications of anticoagulant therapy. Semin Thromb Hemost 1986;12:39-57.